Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FREMANEZUMAB-VFRM vs FRUQUINTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FREMANEZUMAB-VFRM vs FRUQUINTINIB: Safety Overview

Metric FREMANEZUMAB-VFRM FRUQUINTINIB
Total FAERS Reports 9,103 2,565
Deaths Reported 74 874
Death Rate 0.8% 34.1%
Hospitalizations 558 753
Average Patient Age 49.5 yrs 63.9 yrs
% Female Patients 89.2% 44.4%
FDA Approval Date N/A Nov 8, 2023
Manufacturer N/A Takeda Pharmaceuticals America, Inc.
Route N/A ORAL
Marketing Status Prescription Prescription